Cargando…
Clinical Proteomics of Breast Cancer
Despite the lifetimes that increased in breast cancers due to the the early screening programs and new therapeutic strategies, many cases still are being lost due to the metastatic relapses. For this reason, new approaches such as the proteomic techniques have currently become the prime objectives o...
Autores principales: | Baskın, Y., Yiğitbaşı, T. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers Ltd
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048315/ https://www.ncbi.nlm.nih.gov/pubmed/21532837 http://dx.doi.org/10.2174/138920210793175930 |
Ejemplares similares
-
The Value of Serum Biomarkers (Bc1, Bc2, Bc3) in the Diagnosis of Early Breast Cancer
por: Atahan, Kemal, et al.
Publicado: (2011) -
Proteomic maps of breast cancer subtypes
por: Tyanova, Stefka, et al.
Publicado: (2016) -
Breast cancer quantitative proteome and proteogenomic landscape
por: Johansson, Henrik J., et al.
Publicado: (2019) -
Proteomic analysis of the effect of hemin in breast cancer
por: Coló, G. P., et al.
Publicado: (2023) -
Proteomic approaches to early detection of breast cancer
por: Celis, JE, et al.
Publicado: (2005)